Profile for Japan Patent: 4555569
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 4555569
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jun 7, 2026 | Jazz Pharms Therap | VYXEOS | cytarabine; daunorubicin |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
